Director - EMEA Compensation & Benefits Service Centre Lead

Site Name: Warsaw Posted Date: Jul 5 2022 Compensation & Benefits (C&B) Service Centre Lead This is an exciting and unique opportunity to join GSK as Compensation & Benefits (C&B) Service Centre Leader / Director, based in Poland. Job Purpose: The C&B Service Centre Lead has full accountability for Compensation processes and Benefits management (as applicable), within theEMEA region ). The C&B SC Lead will lead avv talented team of C&B experts (in multiple locations supporting circa 44,000 employees), ensuring that work is allocated and delivered in the most efficient and effective way as well as leading our continuous improvement efforts and working as part of a broader global Comp and Bens team. The role will: Ensure the Reward minimum standards are adhered to, that governance processes are in place, that global processes are delivered consistently, and that performance will be tracked and monitored to ensure standards are maintained. Provide expert Compensation and Benefits advice and guidance to above country groups as they benchmark Reward offerings and as new initiatives or schemes are introduced e.g. pensions, car plans, sales incentive plans etc. Lead large Regional Projects / Processes ensuring high quality and efficient deployment Support the development of Reward capability within the Region – both within the Service Centre and Reward Leads and their Teams. They may also be asked to support above country capability building initiatives . Support global projects and process improvements, working with both the Reward CoE and GPO. Above country groups will rely on Regional and Local insights from the Service Centre Lead and their Team to ensure that global processes are culturally diverse and can be implemented. As a member of the EMEA Leadership Team the role will proactively support delivery of People Services initiatives working closely with EMEA colleagues and the l EMEA leadership teams, In addition, this role will connect with Global COE Reward team, ensuring that strategic and operational C&B is connected and aligned across our organisation Your responsibilities: Full accountability for delivery of Compensation processes and Benefits Management in the Region. This includes: The annual Performance & Reward (P&R) cycle, including the annual salary budget setting process Targeted review recommendations (as applicable) Support for Business Unit specific initiatives that span across Regions e.g. the R&D promotions process Participation in process improvement initiatives including After Action Reviews and projects to improve governance / standardization e.g. Bonus Harmonisation Benefits vendor management Support / approvals for benefits changes, as per the Reward Governance Framework (RGF) Management of job evaluation for grades 4-10 within the aligned Region Participation in regional/local networking forums, sourcing pay and benefits data from market providers and negotiating regional / local contracts (as needed). Leadership of the Compensation & Benefits Team for the Region Responsibility for quality of service, effectiveness incl. adherence to governance frameworks and minimum standards (aligned across all Regions) Point of contact for above country groups e.g. Reward CoE, RBLs, HRBLs, as applicable Monitoring of performance and customer experience including identifying where global processes adjustments or simplification may be required (working closely with the Global Process Owner (GPO) and Systems Owners). Responsible for capability building, talent and performance management within the RSC Participation in Global C&B projects (where applicable), providing council and Regional knowledge / expertise Full understanding of Regional C&B data and trends, working closely with the Global Benchmarking Team and via external networking forums – requirement to provide Regional insights, guidance and support to above country teams incl. Reward CoE, RBLs etc, as necessary Why you? Basic Qualifications: Bachelors degree in Human Resources, specifically Compensation and / or Benefits or Accountancy Previous experience in a specialist Compensation and or Benefits role (ideally gained in a large Corporation or a specialist consulting organization) Must have had Regional experience or managed Reward across a group of countries / in a large country Proven experience of Leading a large team of professional C&B Specialists Project Management expertise and / or established experience in managing matrixed / international resources Significant compensation experience gained over multiple, annual process cycles and ongoing operational delivery requirements across multiple countries (i.e. survey providers, interactions with local consultancies, etc.) Business perspective in relevant industry (i.e. Science/ Technology, FMGC) or experience in a Company with multiple business units with at times conflicting requirements Preferred Qualifications: Compensation and / or Benefits certification preferred Evidence of delivery to deadlines/ effective management of multiple activities with conflicting timelines *Li-GSK Why GSK? At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we’re making the most significant changes we’ve made to our business in over 20 years. We’re on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science; and a new world-leading consumer healthcare company of loved and trusted brands. With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together – all with the clear ambition of delivering human health impact; stronger and more sustainable shareholder returns; and as a new GSK where outstanding people thrive. Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that is ambitious for patients – so we deliver what matters better and faster; accountable for impact – with clear ownership of goals and support to succeed; and where we do the right thing. So, if you’re ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together. Pharmaceuticals Our Pharmaceuticals business has a broad portfolio of innovative and established medicines in respiratory, HIV, immuno-inflammation, and oncology. We are strengthening our R&D pipeline by focusing on immunology, human genetics, and advanced technologies to help us deliver transformational new medicines for patients. The business generated sales of £17 billion in 2020. Our strategy is to research and produce innovative, high-quality, and needed medicines, making these as accessible as possible to countries at all levels of income and development. We focus on creating a differentiated pipeline, leading in HIV and respiratory, and developing our presence in specialty therapy areas, including oncology and immuno-inflammation. Our portfolio includes innovative and established medicines, and we have leading global positions in respiratory disease and HIV. We have been a leader in respiratory disease for over 40 years and have a portfolio of mature products. We are creating an agile and more competitive Pharma business equipped to win in a dynamic external environment by improving our pipeline and performance. We will prioritize taking rapid, decisive action to focus the portfolio and accelerate timelines across four core areas to maintain or build global leadership (Respiratory, HIV/Infectious Disease, Oncology, and Immuno-Inflammation). Our integrated Pharma business will become a more competitive organisation: R&D, Manufacturing, and Commercial will combine to simplify decision-making and increase efficiency. Plus, we will continue to be a ‘force for good’ driven equally by competitive performance and our values. Find additional details about our Pharma business and portfolio: Our Pharma business Annual Report 2020 Product Pipeline Vaccines We are one of the world’s largest vaccines companies, delivering vaccines that help protect people at all stages of life. Our R&D focuses on developing vaccines against infectious diseases that combine high medical needs and strong market potential. Our Vaccines business has a portfolio of more than 20 vaccines to help protect people from a range of diseases throughout their lives. We supply these vaccines to people living in over 160 countries. We have a pipeline of 17 candidate vaccines in development at FY 2020, including three for the prevention of Respiratory Syncytial Virus (RSV). In October 2017, our shingles vaccine, Shingrix, received regulatory approval in Canada and the US. The business generated sales of £7 billion in 2020. Our strategy is to bring differentiated and high-quality vaccines to as many people as possible. To achieve this, we focus on creating a strong patient and payer-focused pipeline, maintaining valuable partnerships with our local operating countries, and ensuring sustainable access and affordability. The vaccines in our portfolio have been helping protect people from serious disease for over 100 years, with our Marietta (US) site dedicated to smallpox vaccine production since 1882. Today, our vaccines continue to tackle some of the world’s most devastating diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, and influenza. Innovation is the beating heart of our business. There will be no new vaccines for the many diseases that still threaten individuals, families, and communities worldwide without it. Our R&D organisation brings together expertise in virology, bacterial infection, and different adjuvant platforms. We now have three global R&D hubs: Rockville, USA (new in 2015); Rixensart, Belgium, and Siena, Italy, which are focused on discovering and developing novel vaccines across a range of pressing public health threats. We concentrate our efforts on those possible vaccines that may offer significant improvements over existing options or target diseases for which no vaccines exist. Our approach is to make the most of our expertise while forming complementary partnerships and alliances with others who bring different knowledge and experience. Our vision for the world, where everyone has access to the vaccines they need, depends on a steady supply of great ideas and excellent science. Find additional details about our Vaccines business: GSK Vaccines If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at 1-877-694-7547 (US Toll Free) or +1 801 567 5155 (outside US). GSK is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class. Important notice to Employment businesses/ Agencies GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site. Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting For the Record site.